MedPath

Determination of optimal prophylactic dose of magnesium sulfate for prevention of atrial fibrillation after CABG surgery

Phase 2
Conditions
Atrial fibrillation.
Atrial fibrillation and flutter
Registration Number
IRCT201211124365N15
Lead Sponsor
Vice chancellor for research of Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

signing informed consent; candidate for elective CABG based on angiography; use of cardiopulmonary bypass (CBP) during surgery; no previous history of any cardiac dysrhythmias that is under treatment ( including AF); hemodynamic stability ( MAP>50, heart rate between 50-110); age between 35&75 years old.
Exclusion criteria: history of heart failure (Ejection Fraction less than 30%); more than 4 grafts; renal failure ( serum creatinine >1.5 in two consecutive test); hepatic failure ( liver function tests more than 1.5 times of normal value); history of COPD; hyperthyroidism; serum PH < 7.25 or > 7.55; postoperative MI; second or third degree AV block; need for pacemaker after surgery; reoperation for any reason; history of pervious cardiac surgery; anti-arrhythmic drugs consumption (except beta blocker).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Atrial fibrillation. Timepoint: up to 3 days after operation. Method of measurement: ECG monitoring.
Secondary Outcome Measures
NameTimeMethod
PH. Timepoint: Before Before trial, during the operation,1st day, 2nd day and 3th day after operation, during the operation,1st day, 2nd day and 3th day after operation. Method of measurement: Laboratory kit.;K. Timepoint: Before Before trial, during the operation,1st day, 2nd day and 3th day after operation, during the operation,1st day, 2nd day and 3th day after operation. Method of measurement: Laboratory kit - mEq/L.;Mg. Timepoint: Before Before trial, during the operation,1st day, 2nd day and 3th day after operation, during the operation,1st day, 2nd day and 3th day after operation. Method of measurement: Laboratory kit - mg/dl.
© Copyright 2025. All Rights Reserved by MedPath